K. Wildhagen et Hj. Lakomek, HEMOLYSIS DURING SULFASALAZINE THERAPY IN A PATIENT WITH UNDIFFERENTIATED SPONDYLARTHROPATHY, Aktuelle Rheumatologie, 21(3), 1996, pp. 142-143
A case of a 39-year old patient with undifferentiated spondylarthropat
hy is presented, developing reversible, subclinical hemolysis during l
ow-dose sulfasalazine treatment. Causative for the reduced occurence o
f hemolysis may be the lower dose of sulfasalazine in rheumatoid patie
nts.